R

Redhill Biopharma Ltd
D

RDHL

6.51000
USD
0.09
(1.40%)
Market Closed
Volume
26
EPS
-1
Div Yield
-
P/E
-0
Market Cap
8,336,309
OverviewSignalsIdeasNews
Related Instruments
    AZN
    AZN
    0.265
    (0.39%)
    68.205 USD
    B
    BCRX
    0.01500
    (0.20%)
    7.62000 USD
    BNTX
    BNTX
    -2.010
    (-1.71%)
    115.330 USD
    GILD
    GILD
    0.070
    (0.08%)
    93.020 USD
    I
    INO
    0.06500
    (2.96%)
    2.26000 USD
    MRK
    MRK
    -0.560
    (-0.58%)
    95.670 USD
    MRNA
    MRNA
    2.600
    (7.24%)
    38.490 USD
    N
    NNVC
    0.07000
    (6.25%)
    1.19000 USD
    PFE
    PFE
    -0.621
    (-2.33%)
    26.015 USD
    REGN
    REGN
    -7.47
    (-1.09%)
    679.85 USD
    V
    VSTM
    0.12500
    (2.32%)
    5.51000 USD
    More
News

Title: Redhill Biopharma Ltd

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company alsocommercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.